![](https://endpts.com/wp-content/uploads/2020/12/Evan-Feinberg-Genesis-tile-scaled.jpg)
Evan Feinberg, CEO of Genesis Therapeutics (Boris Feldman)
Genentech-partnered Genesis Therapeutics inks newest AI discovery deal with Eli Lilly
A Stanford biotech rubbed elbows with Genentech in 2020, reaching a deal with the big-name biotech just over 18 months ago. And now, the AI …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.